$MACK Headlines Merrimack Pharma shares surge on

New Post Public Reply Private Reply Replies (0) Message Board

Sep 30, 2014 at 11:49 AM

$MACK Headlines

Merrimack Pharma shares surge on licensing pact with Baxter 7:54 a.m. Sept. 24, 2014 - Tomi Kilgore
Stock futures rise on Bernanke rate comments 5:46 p.m. July 10, 2013 - Wallace Witkowski
Merrimack to offer $50 mln in stock, $75 mln notes 5:24 p.m. July 10, 2013 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
IPO scorecard: Update on selected offering 2:18 p.m. June 8, 2012 - Dow Jones
Shares of Merrimack Pharmaceuticals off post IPO 3:19 a.m. March 30, 2012 - MarketWatch.com

Merrimack Pharmaceuticals (MACK) Strong On High Relative Volume Today 10:01 a.m. Today - TheStreet.com
How Merrimack Pharmaceuticals (MACK) Stock Stands Out in a Strong Industry - Tale of the Tape 8:36 a.m. Sept. 29, 2014 - Zacks.com
Will Merrimack (MACK) Continue to Surge Higher? - Tale of the Tape 10:09 a.m. Sept. 26, 2014 - Zacks.com
Merrimack Pharmaceuticals (MACK) Soars: Stock Adds 7.4% is Session - Tale of the Tape 9:39 a.m. Sept. 26, 2014 - Zacks.com
Baxter and Merrimack Collaborate on Drug Development - Analyst Blog 1:10 p.m. Sept. 25, 2014 - Zacks.com
Update: Merrimack Licenses MM-398 - Value Potential Dramatically Improves 11:30 a.m. Sept. 24, 2014 - Seeking Alpha
Why Merrimack Pharmaceuticals (MACK) Stock Hit a One-Year High Today 10:30 a.m. Sept. 24, 2014 - TheStreet.com
Merrimack Does Well to License Marginal Cancer Drug to Baxter 8:14 a.m. Sept. 24, 2014 - TheStreet.com
Merrimack Pharmaceuticals (MACK): Heavy Pre-Market Activity 8:10 a.m. Sept. 24, 2014 - TheStreet.com
Baxter, Merrimack to Collaborate on Pancreatic Cancer Drug 7:43 a.m. Sept. 24, 2014 - The Wall Street Journal Interactive Edition
Baxter and Merrimack collaborate on cancer drug 7:34 a.m. Sept. 24, 2014 - Seeking Alpha
Market Has Not Yet Noticed Potential in Merrimack Pharmaceuticals (MACK); Have You? - Tale of the Tape 8:39 a.m. Sept. 10, 2014 - Zacks.com
Can Merrimack Pharmaceuticals (MACK) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:43 a.m. Sept. 9, 2014 - Zacks.com
Will Merrimack Pharmaceuticals (MACK) Crush Estimates at Its Next Earnings Report? - Tale of the Tape 8:54 a.m. Aug. 20, 2014 - Zacks.com
10-Q: MERRIMACK PHARMACEUTICALS INC 4:05 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Merrimack Pharmaceuticals' (MACK) CEO Bob Mulroy on Q2 2014 Results - Earnings Call Transcript 3:01 p.m. Aug. 11, 2014 - Seeking Alpha
Update: Merrimack Earnings - Looming Concerns Still Remain 2:04 p.m. Aug. 11, 2014 - Seeking Alpha
More on Merrimack Pharma Q2 results 8:02 a.m. Aug. 11, 2014 - Seeking Alpha
Is Now The Time To Buy Merrimack Pharmaceuticals? 11:17 a.m. July 8, 2014 - Seeking Alpha
They're the Millers: Two Best Funds in Winners' Circle Contest 4:47 p.m. July 6, 2014 - The Wall Street Journal Interactive Edition

Merrimack Pharmaceuticals Presents Additional Phase 2 Biomarker Data Further Strengthening the Finding That MM-121 Increases Progression Free Survival in Patients With Biomarker Positive Metastatic Breast Cancer 8:00 a.m. Today - GlobeNewswire
PharmaEngine and Merrimack Amend MM-398 License Agreement 4:58 a.m. Sept. 26, 2014 - BusinessWire - BZX
Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and Commercialize Novel Cancer Compound MM-398 7:00 a.m. Sept. 24, 2014 - BusinessWire - BZX
Merrimack Pharmaceuticals to Present Clinical and Biomarker Data on Novel Antibody Therapeutics at the ESMO 2014 Congress 8:00 a.m. Sept. 19, 2014 - GlobeNewswire
Merrimack Pharmaceuticals Announces Initiation of HERMIONE, a Randomized Trial of MM-302 in Patients With Advanced HER2-Positive Breast Cancer to Support Application for Accelerated Approval 7:06 a.m. Aug. 11, 2014 - GlobeNewswire
Merrimack Pharmaceuticals Reports Second Quarter 2014 Financial Results 7:01 a.m. Aug. 11, 2014 - GlobeNewswire
Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack Pharma, Sangamo BioSciences, ZIOPHARM Oncology, and Dyax 8:50 a.m. Aug. 7, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals Announces Timing of Second Quarter 2014 Investor Conference Call 4:02 p.m. Aug. 4, 2014 - GlobeNewswire
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals Presents Data From Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer 4:05 p.m. June 25, 2014 - GlobeNewswire
Biotech R&D and Clinical Trials Lead To Potential Revenue Growth - Company's Data of Phase l & Phase ll For HCC Patients Highly Suggestive of Positive Clinical Activity 8:15 a.m. June 25, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals to Regain Worldwide Rights to Develop and Commercialize MM-121 4:15 p.m. June 19, 2014 - GlobeNewswire
Merrimack Pharmaceuticals Announces Oral Presentation of Additional Data Results in Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer 8:01 a.m. June 17, 2014 - GlobeNewswire
Battle of the Biotech Bands - A Great Time for a Great Cause 2:45 p.m. June 12, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals Presents Phase 1 Clinical Data Supporting Four Novel Antibody Therapeutic Programs at the 2014 ASCO Annual Meeting 4:00 p.m. June 2, 2014 - GlobeNewswire
Merrimack Pharmaceuticals Identifies Heregulin as Patient Response Biomarker for MM-121 and Standard of Care Therapy Across Multiple Cancers 9:36 a.m. June 2, 2014 - GlobeNewswire
Fundraising Support, Upcoming Conferences, Clinical Data Presentations, and Cash Dividends - Analyst Notes on WellCare, NPS Pharma, Merrimack Pharmaceuticals, CONMED and Haemonetics 8:00 a.m. May 28, 2014 - PR Newswire - PRF
Equities Marking a New High -- Research on JD.com, NRG Energy, Merrimack Pharma and Arris Group 5:40 a.m. May 28, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference 8:01 a.m. May 27, 2014 - GlobeNewswire
Merrimack Pharmaceuticals to Present Clinical Data Across Oncology Pipeline at ASCO 2014 5:25 p.m. May 22, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nuix Leverages AI for Transformative Legal Review

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Hims & Hers Faces Class Action: Investors Beware

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Softcare Facilitates Standards Delegation Visit to Senegal

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Midea's VitaBreeze: Revolutionizing Personalized Climate

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Asia-Pacific Media Forum Eyes Future Growth Strategies

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

TCL’s AI Vision: Immersive Living at IFA 2026

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

China's Manufacturing: Squeeze or Opportunity?

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Ice-Rock Avalanches: Future Risks and Urgent Lessons

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Mermaid Folklore Meets Revolution in New Short Film

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Changhong's IFA 2026 Showcase: AI, Culture & Localization

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...